Xtl Biopharmaceuticals (XTLB) Current Taxes (2009)
Xtl Biopharmaceuticals (XTLB) posted quarterly Current Taxes of $72000.0 for Q4 2009.
Xtl Biopharmaceuticals (XTLB) Current Taxes (2009) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Current Taxes for 1 consecutive years, with $72000.0 the latest figure, recorded in Q4 2009.
- Quarterly Current Taxes changed N/A year-over-year to $72000.0 in Q4 2009, while the trailing twelve-month figure through Dec 2009 was $72000.0 (changed N/A YoY) and the FY2009 annual result came in at $72000.0, changed N/A from the prior year.
- Current Taxes was little changed at $72000.0 in Q4 2009 per XTLB's latest filing.
- Over the last five years, Current Taxes for XTLB reached as high as $72000.0 in Q4 2009 and fell as low as $72000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 72,000.00 |